{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Matching+Colchicine", "query": { "intervention": "Placebo Matching Colchicine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 16, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Matching+Colchicine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-08T22:35:48.840Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06874192", "title": "Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Statin Adverse Reaction" ], "interventions": [ { "name": "Low-dose colchicine at 0.5mg daily", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2025-03-12", "completion_date": "2026-08-30", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06874192" }, { "nct_id": "NCT02177266", "title": "Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation", "Post-pericardiotomy Syndrome", "Constriction" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2, "start_date": "2015-05", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2017-06-21", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02177266" }, { "nct_id": "NCT06855433", "title": "Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "CPPD - Calcium Pyrophosphate Deposition Disease" ], "interventions": [ { "name": "Colchicine Pill", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 150, "start_date": "2026-07-20", "completion_date": "2030-09-30", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Los Angeles, California • Boston, Massachusetts + 1 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06855433" }, { "nct_id": "NCT03048825", "title": "Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ST Elevation Myocardial Infarction", "Non ST Elevation Myocardial Infarction" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Spironolactone", "type": "DRUG" }, { "name": "SYNERGY Bioabsorbable Polymer Drug-Eluting Stent", "type": "DEVICE" }, { "name": "Colchicine-Placebo", "type": "DRUG" }, { "name": "Spironolactone-Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Population Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7264, "start_date": "2018-02-01", "completion_date": "2024-08-09", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 11, "location_summary": "Bakersfield, California • Washington D.C., District of Columbia • Chicago, Illinois + 8 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Munster", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03048825" }, { "nct_id": "NCT07232069", "title": "PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Artery Disease Risk Factors Multiple", "Coronary Artery Disease Progression", "Prevention & Control", "Premature Atherosclerosis" ], "interventions": [ { "name": "Rosuvastatin 20 Mg Oral Tablet", "type": "DRUG" }, { "name": "Colchicine 0.5 MG Oral Tablet Once Daily", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "30 Years to 60 Years" }, "enrollment_count": 1500, "start_date": "2026-07-21", "completion_date": "2031-07", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Los Angeles, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Hiram", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07232069" }, { "nct_id": "NCT05618353", "title": "The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 700, "start_date": "2023-08-21", "completion_date": "2029-04-30", "has_results": false, "last_update_posted_date": "2026-04-22", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Long Beach, California • Gainesville, Florida + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Buffalo", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05618353" }, { "nct_id": "NCT02594111", "title": "Colchicine in Percutaneous Coronary Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Acute Coronary Syndrome" ], "interventions": [ { "name": "Colchicine vs Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 714, "start_date": "2013-05-30", "completion_date": "2021-12-31", "has_results": true, "last_update_posted_date": "2023-02-21", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02594111" }, { "nct_id": "NCT02139046", "title": "Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gout" ], "interventions": [ { "name": "Febuxostat IR", "type": "DRUG" }, { "name": "Febuxostat XR", "type": "DRUG" }, { "name": "Febuxostat placebo", "type": "DRUG" }, { "name": "Colchicine", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Lansoprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1790, "start_date": "2014-04", "completion_date": "2015-11", "has_results": true, "last_update_posted_date": "2016-11-03", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 192, "location_summary": "Binghamton, Alabama • Birmingham, Alabama • Huntsville, Alabama + 189 more", "locations": [ { "city": "Binghamton", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02139046" }, { "nct_id": "NCT02128490", "title": "Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout", "Moderate Renal Impairment" ], "interventions": [ { "name": "Febuxostat IR", "type": "DRUG" }, { "name": "Febuxostat XR", "type": "DRUG" }, { "name": "Febuxostat placebo", "type": "DRUG" }, { "name": "Colchicine", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Lansoprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 189, "start_date": "2014-05", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2016-11-03", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 89, "location_summary": "Birmingham, Alabama • Muscle Shoals, Alabama • Phoenix, Arizona + 75 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02128490" }, { "nct_id": "NCT06212271", "title": "Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Peripheral Artery Disease" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2024-09-25", "completion_date": "2026-03-25", "has_results": false, "last_update_posted_date": "2026-04-02", "last_synced_at": "2026-09-08T22:35:48.840Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06212271" } ] }